In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rifabutin Pfizer Brand Drug Master File in Korea (Rifabutin Pfizer Brand KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rifabutin Pfizer Brand. The MFDS reviews the Rifabutin Pfizer Brand KDMF as part of the drug registration process and uses the information provided in the Rifabutin Pfizer Brand KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rifabutin Pfizer Brand KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rifabutin Pfizer Brand API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rifabutin Pfizer Brand suppliers with KDMF on PharmaCompass.